Advantech Capital Partners Ii Limited - Net Worth and Insider Trading
Advantech Capital Partners Ii Limited Net Worth
The estimated net worth of Advantech Capital Partners Ii Limited is at least $192 Million dollars as of 2024-11-07. Advantech Capital Partners Ii Limited is the of Alphamab Oncology and owns about 49,691,190 shares of Alphamab Oncology (HKSE:09966) stock worth over $192 Million. Details can be seen in Advantech Capital Partners Ii Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advantech Capital Partners Ii Limited has not made any transactions after 2019-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Advantech Capital Partners Ii Limited
Advantech Capital Partners Ii Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Advantech Capital Partners Ii Limited owns 1 companies in total, including Alphamab Oncology (HKSE:09966) .
Insider Ownership Summary of Advantech Capital Partners Ii Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 |
Advantech Capital Partners Ii Limited Latest Holdings Summary
Advantech Capital Partners Ii Limited currently owns a total of 1 stock. Advantech Capital Partners Ii Limited owns 49,691,190 shares of Alphamab Oncology (HKSE:09966) as of December 12, 2019, with a value of $192 Million.
Latest Holdings of Advantech Capital Partners Ii Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:09966 | Alphamab Oncology | 2019-12-12 | 49,691,190 | 3.87 | 192,304,905 |
Holding Weightings of Advantech Capital Partners Ii Limited
Advantech Capital Partners Ii Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Advantech Capital Partners Ii Limited has made a total of 1 transactions in Alphamab Oncology (HKSE:09966) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Alphamab Oncology is the sale of 0 shares on December 12, 2019, which brought Advantech Capital Partners Ii Limited around $0.
Insider Trading History of Advantech Capital Partners Ii Limited
- 1
Advantech Capital Partners Ii Limited Trading Performance
Advantech Capital Partners Ii Limited Ownership Network
Ownership Network List of Advantech Capital Partners Ii Limited
Ownership Network Relation of Advantech Capital Partners Ii Limited
Advantech Capital Partners Ii Limited Owned Company Details
What does Alphamab Oncology do?
Who are the key executives at Alphamab Oncology?
Advantech Capital Partners Ii Limited is the of Alphamab Oncology. Other key executives at Alphamab Oncology include 2301 Trustee South Dakota Trust Company Llc , 2305 Beneficiary of a trust Xu Ting , and 2307 Founder of a discretionary trust who can infl LIU YANG .
Alphamab Oncology (HKSE:09966) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alphamab Oncology (HKSE:09966) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alphamab Oncology (HKSE:09966) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alphamab Oncology (HKSE:09966)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alphamab Oncology Insider Transactions
Advantech Capital Partners Ii Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Advantech Capital Partners Ii Limited. Currently GuruFocus does not have mailing address information for Advantech Capital Partners Ii Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
